Зачем британское инновационное “озеро” поделили на “прудики”?
Published in Бюллетень Инновационные Тренды • Jan 1, 2011
NobleIDNI6P36W53R35S00
Authors:
Давид Хардман
Abstract
To fully utilize the easily accessible drug-tPA-and the high recanalization rate of MT, it is important to reduce bleeding complications after recanalization. A future study direction could be to investigate the recovery of neurological function by combining reperfusion therapies with cell therapies...
Subject
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!